Exicure (XCUR) Non-Current Debt (2016 - 2021)
Exicure's (XCUR) quarterly Non-Current Debt came in at $16.8 million in Q3 2021, up 1.82% YoY from $16.5 million in Q3 2020, and little changed on a QoQ basis from $16.7 million in Q2 2021.
Exicure (XCUR) Non-Current Debt (2016 - 2021) Analysis & Trends
Exicure (XCUR) has 6 years of Non-Current Debt data on file, last reported at $16.8 million in Q3 2021.
- Quarterly Non-Current Debt rose 1.82% year-over-year to $16.8 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $16.8 million (up 1.82% YoY) and the FY2020 annual result came in at $16.6 million, changed N/A from the prior year.
- Non-Current Debt held at $16.8 million in Q3 2021, from $16.7 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $16.8 million in Q3 2021 to a low of $3.3 million in Q2 2018.
- A 5-year average of $10.1 million and a median of $4.9 million in 2018 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2019 — Non-Current Debt declined 0.28% — and 2020, when it surged 235.91%.
- Tracing XCUR's Non-Current Debt over 5 years: stood at $4.9 million in 2017, then advanced by 1.44% to $4.9 million in 2018, then decreased by 0.26% to $4.9 million in 2019, then surged by 237.72% to $16.6 million in 2020, then grew by 1.28% to $16.8 million in 2021.
- The last three Non-Current Debt figures came in at $16.8 million (Q3 2021), $16.7 million (Q2 2021), and $16.7 million (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn | - |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 8.96 Bn |
| 10 | Exicure | 8.29 Mn | 8.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 16.80 Mn |
| Jun 30, 2021 | 16.73 Mn |
| Mar 31, 2021 | 16.66 Mn |
| Dec 31, 2020 | 16.59 Mn |
| Sep 30, 2020 | 16.50 Mn |
| Sep 30, 2019 | 4.91 Mn |
| Dec 31, 2018 | 4.93 Mn |
| Sep 30, 2018 | 4.93 Mn |
| Jun 30, 2018 | 3.33 Mn |
| Mar 31, 2018 | 4.88 Mn |
| Dec 31, 2017 | 4.86 Mn |
| Dec 31, 2016 | 4.45 Mn |